| 前收市價 | 2.7500 |
| 開市 | 3.1000 |
| 買盤 | 2.0500 |
| 賣出價 | 3.6000 |
| 拍板 | 28.00 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 2.7500 - 3.1000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 6 |
ZacksThe Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics are part of the Zacks top Analyst Blog.
ZacksBiotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Biogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.
ZacksPTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
